申请人:Albert Rolland S.A.
公开号:US04194003A1
公开(公告)日:1980-03-18
The present invention relates to a compound selected from the compounds of the formula: ##STR1## in which: R.sup.1 is selected from hydrogen and C.sub.1-4 alkyl, R is selected from C.sub.1-6 alkyl, benzyl and phenyl, Ar is selected from phenyl, phenyl monosubstituted with a group selected from C.sub.1-4 alkyl, C.sub.1-4 alkoxy and halogen, phenyl polysubstituted with groups selected from C.sub.1-4 alkyl, C.sub.1-4 alkoxy and halogen, naphthyl, naphthyl monosubstituted with a group selected from C.sub.1-4 alkyl, C.sub.1-4 alkoxy and halogen, naphthyl polysubstituted with groups selected from C.sub.1-4 alkyl, C.sub.1-4 alkoxy and halogen, thienyl, furyl and pyrrolyl and > Z represents a carbonyl group, a group of the formula >C.dbd.NOH or an alcoholic group >CHOH and the salts of acids of formula (I) with physiologically acceptable bases. Said compounds are useful for the treatment of hyperuricemia.
本发明涉及一种从以下公式的化合物中选择的化合物:##STR1##其中:R.sup.1从氢和C.sub.1-4烷基中选择,R从C.sub.1-6烷基、苄基和苯基中选择,Ar从苯基、苯基单取代基(所选自C.sub.1-4烷基、C.sub.1-4烷氧基和卤素)、苯基多取代基(所选自C.sub.1-4烷基、C.sub.1-4烷氧基和卤素)、萘基、萘基单取代基(所选自C.sub.1-4烷基、C.sub.1-4烷氧基和卤素)、萘基多取代基(所选自C.sub.1-4烷基、C.sub.1-4烷氧基和卤素)、噻吩基、呋喃基和吡咯基,> Z代表羰基,一个公式的基团 >C.dbd.NOH 或一个醇基团 >CHOH,以及具有生理学上可接受的碱的酸的盐的化合物。这些化合物对于治疗高尿酸血症是有用的。